View Older Stories
-
This stock is a new preferred major pharma pick at Citi
-
Tesla, XPeng, Nio rise premarket; AstraZeneca, AMC Entertainment fall
-
2 Reasons Why Citi Downgraded Merck (MRK) to Neutral Today, Opened a Negative Catalyst Watch
-
AstraZeneca (AZN) Up as Earnings Top Estimates, On Track to Deliver COVID-19 Vaccines, Analysts Positive on Core Business Performance
-
AstraZeneca (AZN) Put on Positive Catalyst Watch at Citi
-
Analysis: Australia's star vaccine maker not immune to virus anxiety
-
AstraZeneca, Gilead merger doubted by Wall Street analysts
-
Citi Reiterates Buy Rating on Novartis (NVS)
-
AstraZeneca (AZN:LN) (AZN) PT Raised to GBP100 at Citi, Remains on Focus List
-
Citi Reiterates Buy Rating on AstraZeneca (AZN), Closes Catalyst Watch
-
As steep patent cliff looms, Shionogi moves to develop its own U.S. sales staff
-
Citi Reiterates Buy Rating on AstraZeneca (AZN)
-
UPDATE: Citi Downgrades Eli Lilly (LLY) to Neutral
-
AstraZeneca (AZN:LN) (AZN) PT Raised to GBp7,000 at Citi
-
Dividends a worry at drugmakers Astra, GSK after dramatic week
-
Complete Donald Trump Stock Impact Guide
-
Pre-Open Stock Movers 05/27: (RLYP) (TTNP) (FEIX) Higher; (HERO) (UNXL) (TEX) Lower (more...)
-
Notable Analyst Rating Changes 4/12: (CHK) (YNDX) (HLX) Upgraded; (AZN) (SBUX) (LB) Downgraded
-
Merck (MRK) Said to be Interested in Relypsa (RLYP) - Source
-
Relypsa (RLYP) Could Be Next High-Profile Takeout, Says Citi
-
Wall St. flat as rate hike eyed; banks counter utilities drop
-
Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
-
Notable Analyst Rating Changes 7/2: (T) (KOS) (KIM) Upgraded; (GNRC) (BTU) (RF) Downgraded
-
Loeb's Third Point LLC 13F Shows Ally (ALLY), Rackspace (RAX), IAC/InterActiveCorp (IACI), Finisar Corp. (FNSR) Entry (more...)
-
Citi Upgrades AstraZeneca (AZN) to Buy
-
Pre-Open Movers 4/21: (SRPT) (CBEY) (ASTM) Higher; (ATHN) (WLT) (PEIX) Lower (more...)
-
Notable Analyst Rating Changes 03/03: (NOK) (KATE) (TDS) Upgraded; (ADSK) (AZN) (RIO) Downgraded
-
Notable Analyst Rating Changes 09/03: (APA) (NOK) (KEG) Upgraded; (AAPL) (KO) (LF) Downgraded
-
Market Wrap: Berlusconi Cedes; Activision Answers Q3 Call (of Duty); Targacept's Bad Day; McDonald's Sizzles in October
-
Berkowitz's Fairholme Shows New Stake in Jefferies (JEF), Ups Stake In AIG (AIG), BofA (BAC), Citi (C); Liquidates Cisco (CSCO)
-
Berkowitz's Fairholme Picks Up Pharma Stakes, and Cisco (CSCO); Swaps General Growth (GGP) for Brookfield (BAM)
-
Daily State of the Markets 01/11: Bulls, Bears (and Cubbies)
-
Citi Upgrades AstraZeneca (AZN) to Buy
-
Notable Analyst Rating Changes 09/29: CPE, ENDP, SCS, SPIL Upgraded; AZN, JCG, AMGN, WBSN Downgraded
-
Lampert's RBS Partners Reduces Holdings, Gets Financial Exposure with Genworth (GNW)
-
Trading Radar for 01/28: Amazon.com (AMZN), Microsoft (MSFT), Chubb (CB), AT&T (T), Ford Motor (F), L-3 (LLL) Report
-
Notable Analyst Rating Changes 11/09: RSH, ANF, NOC, ADBE, HERO Upgraded; RIMM, RHT, GPS, AZN, SGY Downgraded
-
Notable Analyst Rating Changes 9/29: RL, PVH, COP, USB, BRCM, ATHN, MOV Upgraded; SNV, AZN, PD, FRP Downgraded
-
Notable Analyst Rating Changes 9/24: MTH, NSM, WFC, AIMC, CPN, SHFL Higher; LLL, AZN, VIP, ANN, KGC, UFS Downgraded
-
Notable Analyst Rating Changes 8/20: SOL, JACK, PRU, LULU, CHA Upgraded; RF, BCSI, AZN, BUCY, JOYG, UA Downgraded
-
Citi Downgrades AstraZeneca (AZN) to Hold
-
David Moenning's Daily State of the Markets: 6/15
-
Citi Upgrades AstraZeneca (AZN) to Buy
-
David Moenning's Daily State of the Markets: 4/30
-
Notable Analyst Rating Changes 4/27: BUCY, JOYG, MMM, NFLX Upgraded; BNI, HON, MAR, SONC Downgraded
-
Notable Analyst Rating Changes 1/30: TER, TRA, AZN, BSX Upgraded; X, ALL, SGP, UA Downgraded
-
Citi Downgrades AstraZeneca (AZN) to Hold
-
David Moenning's Daily State of the Markets: 1/29
-
Citi Analysts Call 2009 Global Equity Outlook 'Battling The Bear' - Issue Global Preferred List
-
Notable Analyst Rating Changes 10/29: BIIB, MTH, PCU Upgraded; JNJ, SWIR, ULTI Downgraded

